Intravascular Renal Denervation Reduces Ambulatory and Office Blood Pressure in Patients with Essential Hypertension: A Meta-Analysis of Randomized Sham-Controlled Trials
Background: This meta-analysis was designed to evaluate the antihypertensive efficacy of intravascular renal denervation (RDN) in patients with essential hypertension, especially to determine the magnitude of blood pressure (BP) reduction with RDN therapy using second-generation catheters. Methods:...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2022-04-01
|
| Series: | Kidney & Blood Pressure Research |
| Subjects: | |
| Online Access: | https://www.karger.com/Article/FullText/524171 |
| _version_ | 1828385755365376000 |
|---|---|
| author | Xiaoxv Yang Hui Liu Shifang Chen Pingshuan Dong Di Zhao |
| author_facet | Xiaoxv Yang Hui Liu Shifang Chen Pingshuan Dong Di Zhao |
| author_sort | Xiaoxv Yang |
| collection | DOAJ |
| description | Background: This meta-analysis was designed to evaluate the antihypertensive efficacy of intravascular renal denervation (RDN) in patients with essential hypertension, especially to determine the magnitude of blood pressure (BP) reduction with RDN therapy using second-generation catheters. Methods: PubMed was searched to identify randomized sham-controlled trials from inception through August 2021. The endpoints were changes in 24-h ambulatory BP or office BP. This meta-analysis was performed by calculating the weighted mean difference (WMD) with 95% confidence interval (CI) using the random-effects model when the I2 index was <50%. A fixed-effects model was used when the I2 index was ≥50%. Results: A total of 1,297 patients were included in 8 randomized, sham-controlled trials in this meta-analysis. Intravascular RDN reduced 24-h ambulatory systolic BP (SBP) −3.02 (WMD, 95% CI: −4.95, −1.10, p < 0.01) and diastolic BP (DBP) −1.66 (WMD, 95% CI: −2.44, −0.88, p < 0.001) mm Hg, respectively. In the studies using first-generation catheters, the WMDs of 24-h ambulatory SBP and DBP changes between intravascular RDN and sham control were −2.67 (95% CI: −5.08, −0.27; p < 0.05; I2 = 0%, p = 0.53) and −0.82 (95% CI: −2.19, 0.56; p > 0.05; I2 = 0%, p = 0.64) mm Hg. In the studies using second-generation catheters, the WMDs of 24-h ambulatory SBP and DBP changes between intravascular RDN and sham control were −3.14 (95% CI: −5.94, −0.33, p < 0.05; I2 = 71%, p = 0.008) and −2.06 (95% CI: −3.02, −1.11, p < 0.001; I2 = 50%, p = 0.09) mm Hg. Intravascular RDN using second-generation catheters reduced office SBP −6.30 (WMD, 95% CI: −7.67, −4.93, p < 0.001; I2 = 43%, p = 0.14) and DBP −3.88 (WMD, 95% CI: −4.44, −3.33, p < 0.001; I2 = 42%, p = 0.14) mm Hg, respectively. Conclusions: Intravascular RDN using second-generation catheters reduces ambulatory and office BP in patients with essential hypertension. The selection of appropriate hypertensive patients may be the major challenge for the performance of intravascular RDN in routine clinical practice. |
| first_indexed | 2024-12-10T05:25:17Z |
| format | Article |
| id | doaj.art-5c09b5f2b70641b3928b43a39272dcf0 |
| institution | Directory Open Access Journal |
| issn | 1420-4096 1423-0143 |
| language | English |
| last_indexed | 2024-12-10T05:25:17Z |
| publishDate | 2022-04-01 |
| publisher | Karger Publishers |
| record_format | Article |
| series | Kidney & Blood Pressure Research |
| spelling | doaj.art-5c09b5f2b70641b3928b43a39272dcf02022-12-22T02:00:42ZengKarger PublishersKidney & Blood Pressure Research1420-40961423-01432022-04-0110.1159/000524171524171Intravascular Renal Denervation Reduces Ambulatory and Office Blood Pressure in Patients with Essential Hypertension: A Meta-Analysis of Randomized Sham-Controlled TrialsXiaoxv Yang0Hui Liu1Shifang Chen2Pingshuan Dong3Di Zhao4Division of Cardiology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, ChinaDivision of Endocrinology, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, ChinaDivision of Cardiology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, ChinaDivision of Cardiology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, ChinaCardiovascular Institute, Henan University of Science and Technology, Luoyang, ChinaBackground: This meta-analysis was designed to evaluate the antihypertensive efficacy of intravascular renal denervation (RDN) in patients with essential hypertension, especially to determine the magnitude of blood pressure (BP) reduction with RDN therapy using second-generation catheters. Methods: PubMed was searched to identify randomized sham-controlled trials from inception through August 2021. The endpoints were changes in 24-h ambulatory BP or office BP. This meta-analysis was performed by calculating the weighted mean difference (WMD) with 95% confidence interval (CI) using the random-effects model when the I2 index was <50%. A fixed-effects model was used when the I2 index was ≥50%. Results: A total of 1,297 patients were included in 8 randomized, sham-controlled trials in this meta-analysis. Intravascular RDN reduced 24-h ambulatory systolic BP (SBP) −3.02 (WMD, 95% CI: −4.95, −1.10, p < 0.01) and diastolic BP (DBP) −1.66 (WMD, 95% CI: −2.44, −0.88, p < 0.001) mm Hg, respectively. In the studies using first-generation catheters, the WMDs of 24-h ambulatory SBP and DBP changes between intravascular RDN and sham control were −2.67 (95% CI: −5.08, −0.27; p < 0.05; I2 = 0%, p = 0.53) and −0.82 (95% CI: −2.19, 0.56; p > 0.05; I2 = 0%, p = 0.64) mm Hg. In the studies using second-generation catheters, the WMDs of 24-h ambulatory SBP and DBP changes between intravascular RDN and sham control were −3.14 (95% CI: −5.94, −0.33, p < 0.05; I2 = 71%, p = 0.008) and −2.06 (95% CI: −3.02, −1.11, p < 0.001; I2 = 50%, p = 0.09) mm Hg. Intravascular RDN using second-generation catheters reduced office SBP −6.30 (WMD, 95% CI: −7.67, −4.93, p < 0.001; I2 = 43%, p = 0.14) and DBP −3.88 (WMD, 95% CI: −4.44, −3.33, p < 0.001; I2 = 42%, p = 0.14) mm Hg, respectively. Conclusions: Intravascular RDN using second-generation catheters reduces ambulatory and office BP in patients with essential hypertension. The selection of appropriate hypertensive patients may be the major challenge for the performance of intravascular RDN in routine clinical practice.https://www.karger.com/Article/FullText/524171hypertensionintravascular renal denervationmeta-analysis |
| spellingShingle | Xiaoxv Yang Hui Liu Shifang Chen Pingshuan Dong Di Zhao Intravascular Renal Denervation Reduces Ambulatory and Office Blood Pressure in Patients with Essential Hypertension: A Meta-Analysis of Randomized Sham-Controlled Trials Kidney & Blood Pressure Research hypertension intravascular renal denervation meta-analysis |
| title | Intravascular Renal Denervation Reduces Ambulatory and Office Blood Pressure in Patients with Essential Hypertension: A Meta-Analysis of Randomized Sham-Controlled Trials |
| title_full | Intravascular Renal Denervation Reduces Ambulatory and Office Blood Pressure in Patients with Essential Hypertension: A Meta-Analysis of Randomized Sham-Controlled Trials |
| title_fullStr | Intravascular Renal Denervation Reduces Ambulatory and Office Blood Pressure in Patients with Essential Hypertension: A Meta-Analysis of Randomized Sham-Controlled Trials |
| title_full_unstemmed | Intravascular Renal Denervation Reduces Ambulatory and Office Blood Pressure in Patients with Essential Hypertension: A Meta-Analysis of Randomized Sham-Controlled Trials |
| title_short | Intravascular Renal Denervation Reduces Ambulatory and Office Blood Pressure in Patients with Essential Hypertension: A Meta-Analysis of Randomized Sham-Controlled Trials |
| title_sort | intravascular renal denervation reduces ambulatory and office blood pressure in patients with essential hypertension a meta analysis of randomized sham controlled trials |
| topic | hypertension intravascular renal denervation meta-analysis |
| url | https://www.karger.com/Article/FullText/524171 |
| work_keys_str_mv | AT xiaoxvyang intravascularrenaldenervationreducesambulatoryandofficebloodpressureinpatientswithessentialhypertensionametaanalysisofrandomizedshamcontrolledtrials AT huiliu intravascularrenaldenervationreducesambulatoryandofficebloodpressureinpatientswithessentialhypertensionametaanalysisofrandomizedshamcontrolledtrials AT shifangchen intravascularrenaldenervationreducesambulatoryandofficebloodpressureinpatientswithessentialhypertensionametaanalysisofrandomizedshamcontrolledtrials AT pingshuandong intravascularrenaldenervationreducesambulatoryandofficebloodpressureinpatientswithessentialhypertensionametaanalysisofrandomizedshamcontrolledtrials AT dizhao intravascularrenaldenervationreducesambulatoryandofficebloodpressureinpatientswithessentialhypertensionametaanalysisofrandomizedshamcontrolledtrials |